Haleon plc (HLNCF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 03:31PM EDT
| Previous close | 4.1246 |
| Open | 4.1700 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 4.0800 - 4.1700 |
| 52-week range | 3.4000 - 4.5000 |
| Volume | |
| Avg. volume | 41,048 |
| Market cap | 37.717B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 29.14 |
| EPS (TTM) | 0.1400 |
| Earnings date | N/A |
| Forward dividend & yield | 0.08 (1.85%) |
| Ex-dividend date | 14 Mar 2024 |
| 1y target est | N/A |
Simply Wall St.Haleon plc (LON:HLN) Shares Could Be 24% Above Their Intrinsic Value Estimate
Key Insights Using the 2 Stage Free Cash Flow to Equity, Haleon fair value estimate is UK£2.62 Haleon is estimated to...
ZacksPharma Stock Roundup: AZN to Buy FUSN, PFE to Sell Stake in HLN & Other Updates
AstraZeneca (AZN) is set to acquire Fusion Therapeutics (FUSN). Pfizer (PFE) plans to sell some shares of Haleon to lower stake from 32% to 24%.
ZacksGSK Outperforms Industry on Strength in Key Drugs & Vaccines
Strong sales growth of GSK's specialty drugs and vaccines, the contribution from new products and positive pipeline updates should drive the stock in the future quarters.
© 2024 Yahoo. All rights reserved.